Although multi-gene combination therapy is far more effective than selective gene therapy, it still cannot completely inhibit glioma growth, and further studies are suggested [95,97,98].>In another study, researchers used Notch1 siRNA to reduce Notch1 function and increase Plasmid-induced Notch2 expression. The gene discussed is NOTCH1; the disease is central nervous system cancer.